GoodRx Holdings (GDRX) Free Cash Flow (2019 - 2026)

GoodRx Holdings' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$8.7 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 29.63% year-over-year to -$8.7 million; the TTM figure through Mar 2026 stood at $101.1 million (down 21.14% YoY), while the FY2025 annual figure was $97.4 million, down 46.67% from the prior year.
• Free Cash Flow came in at -$8.7 million for Q1 2026 at GoodRx Holdings, down from $18.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $86.5 million in Q3 2024 to a low of -$12.3 million in Q1 2025.
• A 5-year average of $29.3 million and a median of $31.7 million in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow soared 1209.28% in 2024 and sank 129.21% in 2025, its largest moves.
• GoodRx Holdings' Free Cash Flow stood at $31.7 million in 2022, then slumped by 89.27% to $3.4 million in 2023, then jumped by 1209.28% to $44.6 million in 2024, then plunged by 58.95% to $18.3 million in 2025, then slumped by 147.38% to -$8.7 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$8.7 million, $18.3 million, and $20.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison